Mixlab

Mixlab

A next-gen veterinary compounding pharmacy.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor investor investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor investor investor investor

€0.0

round
*

$10.0m

Valuation: $100m

Series A
Total Funding000k
Notes (0)
More about Mixlab
Made with AI
Edit

Mixlab operates as a veterinary-partnered pharmacy, focusing on the creation and delivery of customized medications for pets. The company was established in 2017 by Frederic Dijols, Vinnie Dam, and Stella Kim. Dijols, the CEO, drew from his experience in healthcare investment banking at J.P. Morgan and as a medical device engineer at Johnson & Johnson, along with an MBA from Harvard and an M.S. from Stanford. Dam, the Chief Pharmacy Officer, brought his experience as a pharmacist and district manager for Rite Aid, combined with a passion for animal health. The founding trio aimed to simplify the often difficult process of medicating pets by creating more palatable and easy-to-administer treatments.

The company's primary clients are veterinarians and pet owners. Its business model revolves around partnering with veterinarians who write and manage prescriptions through Mixlab's proprietary digital platform. This system is designed to streamline the prescription process, moving away from traditional faxes and phone calls. For pet owners, Mixlab offers a direct-to-home delivery service for these medications. Revenue is generated from the sale of these custom-compounded and commercial medications. The company has secured significant funding, including a $10 million round in August 2023 and a $20 million Series A in August 2021, totaling over $40 million to date from investors like Vanterra Ventures, Global Founders Capital, and Sonoma Brands Capital.

Mixlab's core service is providing compounded medications, which involves customizing the dosage, form (such as liquids, treats, or transdermal gels), and flavor of a pet's prescription to improve compliance. They offer over 30 flavor options to make medications more appealing to animals. In addition to compounded drugs, Mixlab's offerings are expanding to include branded and generic medications, as well as over-the-counter products, positioning itself as a comprehensive pet health provider. A key feature of their service is fast delivery, offering free next-day shipping across all 50 states and same-day delivery in metropolitan areas like New York, Los Angeles, and Miami. The company has also made strategic acquisitions, such as NexGen Animal Health, to expand its services to include large animals like horses, wildlife, and zoo animals.

Keywords: veterinary pharmacy, pet medication, compounding pharmacy, animal health, pet prescriptions, veterinary services, custom pet medication, direct-to-consumer pet care, online pet pharmacy, pet wellness, veterinary drug compounding, e-prescribing for veterinarians, pet healthcare solutions, animal drug delivery, customized veterinary drugs, same-day pet meds, veterinary technology, PCAB accredited pharmacy, companion animal health, equine pharmacy

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Mixlab

Edit
The Pet Apothecary
ACQUISITION by Mixlab Jan 2025
SBH Medical
ACQUISITION by Mixlab Jan 2025
NexGen Pharmaceuticals
ACQUISITION by Mixlab May 2024